|
|||||
|
|
| 山西省太原地区乙型病毒性肝炎经济负担影响因素分析 | |
| 引用本文： | 李俊华,刘近春,张顺祥,庄贵华,刘保芳,冯亦农.山西省太原地区乙型病毒性肝炎经济负担影响因素分析[J].中国现代医生,2011,49(9):103-105. |
| 作者姓名： | 李俊华 刘近春 张顺祥 庄贵华 刘保芳 冯亦农 |
| 作者单位： | 1. 山西医科大学第一医院消化内科,山西太原,030001 2. 深圳市疾病预防控制中心,广东深圳,518020 3. 西安交大医学部公共卫生学院,陕西西安,710049 4. 太原市第三人民医院,山西太原,030001 |
| 基金项目： | 国家"十一五"科技重大专项课题 |
| 摘 要： | 目的了解山西省太原地区住院乙肝患者的疾病经济负担并探讨其影响因素。方法采用整群抽样方法选取样本，利用问卷方式进行调查，SPSS13．0统计软件进行统计分析。结果山西省太原地区乙肝患者本次住院人均疾病直接费用为（22527．18±21755．36）元，间接费用为（2250．64±2173．39）元，总费用为（24777．82±23171．55）元。年龄、户籍、职业、医疗保障和住院天数分别对各项费用影响有统计学意义。结论乙肝患者的疾病经济负担非常重，应进一步加大政府投入，提高基层医疗机构的疾病诊治能力，将乙肝抗病毒药物更多地纳入医疗保障中，以降低乙肝患者的经济负担。 |
| 关 键 词： | 乙型病毒性肝炎 经济负担 影响因素 |
Research on the Ecnomic Burden and Its Influencing Factors of the Patients Suffering from Type B Viral Hepatitis in Shanxi Taiyuan |
|
| Authors: | LI Junhua LIU Jinchun ZHANG Shunxiang ZHUANG Guihua LIU Baofang FENG Yinong |
| Institution: | LI Junhua1 LIU Jinchun1 ZHANG Shunxiang2 ZHUANG Guihua3 LIU Baofang4 FENG Yinong4 1.Dept of Digestion,First Clinic Medical College,Shanxi Medical University,Taiyuan 030001,China,2.The Center for Disease Control and Prevention of Shenzhen City,Shenzhen 518020,3.School of Public Health,Department of Medical of Xian Jiaotong University,Xian 710049,4.Taiyuan City Third People's Hospital |
| Abstract: | Objective To investigate the economic burden of type B viral hepatitis patients in Taiyuan Shanxi province and explore its influencing factors. Methods The samples were randomly selected using cluster sampling method, surveyed by self-made questionnaire and analyzed by SPSS13.0. Results Type B viral hepatitis patients per capita direct economic burden was（22527.18 ±21755.36） yuan,indirect economic burden was （2250.64±2173.39）yuan,total economic burden was （24777.82±23171.55）yuan.The age,census register,vocation,medical security and days in hospital have a statistically significant impact on the economic burden of type B viral hepatitis patients. Conclusion Type B viral hepatitis patients per capita economic burden was heavy,the government should increase investment. The capacity of diagnosis and treatment should be improved in basic medical institutions. The antiviral drugs should also be put more into the health insurance so as to reduce the financial burden of the disease. |
| Keywords: | Type B viral hepatitis Economic burden Influencing factors |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ | |